Citi notched its estimate for incretin drug sales to $71 billion by 2035, up from its prior estimate of $55 billion. That view seems conservative. Here’s…
Most analysts predict the market for new weight loss drugs like Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask.
Guggenheim analyst Seamus Fernandez's conviction comes from his belief that GLP-1-based incretins will become the most prescribed drugs ever by or before 2031. Not only do these drugs work well for managing insulin levels and helping patients lose weight, studies are underway to show their benefits for
Citi's forecast does reflect more modest assumptions. It is assuming the number of patients opting for the weekly injections will be below 10% of the non-Medicare obese patient population. The drugs are very pricey, with a list price of as much as $1,350 per month for Wegovy. At the moment, private insurance coverage isn't a guarantee for those seeking weight loss treatment, and the federal Medicare program doesn't cover weight loss drugs at all.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Databricks, the $43 billion analytics firm, acquires data startup Arcion for $100 millionDatabricks agreed to acquire Arcion, an enterprise data company, for $100 million Monday, including incentives, CEO Ali Ghodsi told CNBC.
Read more »
Databricks, the $43 billion analytics firm, acquires data startup Arcion for $100 millionDatabricks agreed to acquire Arcion, an enterprise data company, for $100 million Monday, including incentives, CEO Ali Ghodsi told CNBC.
Read more »
Carrie Ann Inaba says Madonna charged dancers $100 per minute for being late: 'She was very strict'Carrie Ann Inaba says Madonna charged backup dancers $100 per minute when they were late.
Read more »
Dallas browser startup Island reels in another $100 million investmentIsland is one of seven privately owned North Texas companies considered to have valuations exceeding $1 billion.
Read more »
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbersCiti notched its estimate for incretin drug sales to $71 billion by 2035, up from its prior estimate of $55 billion. That view seems conservative. Here's why.
Read more »
Stock futures edge higher on Sunday night as Wall Street awaits big tech earnings: Live updatesStock futures ticked higher on Sunday night, ahead of a big week of earnings reports and key economic data releases.
Read more »